<?xml version="1.0" encoding="UTF-8"?>
<ref id="dkx118-B34">
 <label>34</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Clotet</surname>
    <given-names>B</given-names>
   </name>,
   <name name-style="western">
    <surname>Feinberg</surname>
    <given-names>J</given-names>
   </name>,
   <name name-style="western">
    <surname>van Lunzen</surname>
    <given-names>J</given-names>
   </name>
  </person-group>
  <etal/>
  <article-title>Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study</article-title>. 
  <source>Lancet</source>
  <year>2014</year>;
  <volume>383</volume>: 
  <fpage>2222</fpage>–
  <lpage>31</lpage>.
  <pub-id pub-id-type="pmid">24698485</pub-id>
 </mixed-citation>
</ref>
